Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United Kingdom
University Hospitals Birmingham NHS Foundation Trust, Birmingham Leeds Teaching Hospitals NHS Trust, Leeds Guy's & St Thomas NHS Foundation Trust, London Royal Free London NHS Foundation Trust, London Newcastle Upon Tyne NHS Foundation Trust, Newcastle University of Oxford - The Kennedy Institute, Oxford